← Leaderboards
Maria A Croyle
University Of Texas Austin
$3,234,269
Attributed
$3,234,269
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $706.7K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,234,269 · 6
By mechanism
U01$2,546,250 · 1
R21$633,125 · 2
P51$54,894 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Austin
Same institution · by research overlap
- Jonathan L. Sessler$8,611,847
- Swathi Kiran$11,515,451
- Risto Miikkulainen$4,642,999
- Krishnendu Roy$9,091,105
- Maya Escobar$27,559
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseImmune ResponseDoseAnimal ModelEvaluationPathogenOralInfectionVaccinesPlayAntigensAdjuvantBiochemicalVaccination StrategyBaseB-LymphocytesImmunizationCell Mediated Immune ResponseRouteLightToxic EffectVaccine DevelopmentNonhuman PrimateAdenoviruses
Grant awards (12)
Cinnamon and Spice as Adjuvants are Nice? Evaluation of Transient Receptor Potential Channels as Targets to Improve Bioavailabilty of and the Immune Response to Film-Based Oral Vaccines$228,125
R21 · FY2020 · AI · contact PI
Cinnamon and Spice as Adjuvants are Nice? Evaluation of Transient Receptor Potential Channels as Targets to Improve Bioavailabilty of and the Immune Response to Film-Based Oral Vaccines$189,000
R21 · FY2019 · AI · contact PI
Evaluation of Protective Immunity After Mucosal Vaccination Against Ebola Virus$618,441
U01 · FY2012 · AI · contact PI
Evaluation of Protective Immunity After Mucosal Vaccination Against Ebola Virus$706,731
U01 · FY2011 · AI · contact PI
Evaluation of Protective Immunity After Mucosal Vaccination Against Ebola Virus$460,021
U01 · FY2010 · AI · contact PI
Evaluation of Protective Immunity After Mucosal Vaccination Against Ebola Virus$380,631
U01 · FY2009 · AI · contact PI
Evaluation of Protective Immunity After Mucosal Vaccination Against Ebola Virus$380,426
U01 · FY2008 · AI · contact PI
IMMUNOLOGY AND BIOLOGY OF PEGYLATED ADENOVIRUS AFTER A SINGLE DOSE$4,124
P51 · FY2008 · RR · contact PI
IMMUNOLOGY AND BIOLOGY OF PEGYLATED ADENOVIRUS AFTER A SINGLE DOSE$28,122
P51 · FY2006 · RR · contact PI
Virus-Receptor Interaction and CYP3A Expression$108,000
R21 · FY2005 · GM
IMMUNOLOGY AND BIOLOGY OF PEGYLATED ADENOVIRUS AFTER A SINGLE DOSE$22,648
P51 · FY2005 · RR
Virus-Receptor Interaction and CYP3A Expression$108,000
R21 · FY2004 · GM